Randomized phase II study with UFT capsule /LV or UFT E-granule /LV adjuvant chemotherapy for patients with completely resected high-risk stage II and III colorectal cancer
Phase 2
Recruiting
- Conditions
- colorecrtal cancer
- Registration Number
- JPRN-UMIN000010980
- Lead Sponsor
- HORE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
A patient: 1)with administration contraindications for UFT,LV. 2)with active synchronous or metachronous malignancy other than carcinoma in situ(within 5 years). 3)has severe postoperative complications such as serious postoperative infectious disease,anastomotic leak and gastrointestinal bleeding. 4) has severe diarrhea. 5)has severe drug hypersensitivity. 6)is a pregnant woman or a woman suspected of being pregnant,or,is a man who hopes to make his partner pregnant. 7)with psychosis or psychoneurosis. 8)In case that the doctor judged that he/she is disqualified for the enrollment in this clinical trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method